logo

For the Inventor, By the Inventor

Houston, TX, United States of America

Muslim D Shahid

This inventor holds 10 USPTO granted patents. Top assignees: Baker Hughes Corporation, Other. Active years: 2000-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Muslim D Shahid. Retrieved from https://idiyas.com/inventor/muslim-d-shahid

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10

% Patents Active = 100.0

Average Co-Inventor Count = 1.1

ph-index = 4

Forward Citations = 44(Granted Patents)


Location History:

  • Houston, TX (US) (2000 - 2004)
  • Spring, TX (US) (2016 - 2022)

Company Filing History:

goldMedal8 out of 5,728 
 
Baker Hughes Corporation
 patents
silverMedal2 out of 834,513 
Other
 patents

Years Active: 2000-2022

Loading Chart...
10 patents (USPTO):Explore Patents
1. 11273145 - Compositions and methods for the treatment of acid-related gastrointestinal disorders containing a dithiolane compound and a gastric acid secretion inhibitor (2022-03-15),
2. 9457011 - Compositions and methods for the treatment of acid-related gastrointestinal disorders containing a dithiolane compound and a gastric acid secretion inhibitor (2016-10-04),
3. 6686422 - Inhibition of popcorn polymer growth (2004-02-03),
4. 6673879 - Use of diamines and alkanolamines to inhibit unsaturated monomer polymerization (2004-01-06),
5. 6525147 - Use of diamines and alkanolamines to inhibit unsaturated monomer polymerization (2003-02-25),
6. 6525146 - Inhibition of popcorn polymer growth (2003-02-25),
7. 6342648 - Methods and compositions for inhibiting vinyl aromatic monomer polymerization (2002-01-29),
8. 6342647 - Vinyl monomer polymerization inhibition using hindered hydroxylamines (2002-01-29),
9. 6284936 - Styrene monomer polymerization inhibition using substituted dihydroxyarenes and nitroxides (2001-09-04),
10. 6025515 - Use of substituted phenols to inhibit polymer formation during the (2000-02-15),

Title: Innovations by Muslim D Shahid in Gastrointestinal Treatments

Introduction

Muslim D Shahid is an accomplished inventor based in Houston, TX (US). He has made significant contributions to the field of gastrointestinal treatments, holding a total of 10 patents. His work focuses on innovative compositions and methods aimed at improving the treatment of acid-related gastrointestinal disorders.

Latest Patents

One of his latest patents involves compositions and methods for the treatment of acid-related gastrointestinal disorders that contain a dithiolane compound and a gastric acid secretion inhibitor. This treatment is particularly noteworthy as it combines gastric acid secretion inhibitors with alpha lipoic acid (ALA) or related compounds. Although ALA is not traditionally recognized as a treatment for acid-related gastrointestinal disorders, its combination with specific compounds enhances existing treatment options significantly.

Another patent also addresses the treatment of acid-related gastrointestinal disorders using similar compounds. The methods described in this patent highlight the potential of ALA, when paired with known gastric acid secretion inhibitors, to improve therapeutic outcomes for patients suffering from these conditions.

Career Highlights

Throughout his career, Muslim D Shahid has worked with notable companies, including Baker Hughes Corporation. His innovative approach and dedication to research have led to advancements in the treatment of gastrointestinal disorders, showcasing his expertise in the field.

Collaborations

Muslim D Shahid has collaborated with various professionals, including Glenn L Roof, to further his research and development efforts. These collaborations have played a crucial role in enhancing the effectiveness of his inventions.

Conclusion

Muslim D Shahid's contributions to the field of gastrointestinal treatments through his innovative patents demonstrate his commitment to improving patient care. His work continues to pave the way for advancements in medical treatments, particularly for acid-related gastrointestinal disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…